Volume 6, Issue 1, February Issue - 2018, Pages:62-86
|Authors: Rajendra Singh*, K.P. Singh,M. Saminathan, Vineetha, S, G.B. Manjunatha Reddy, Madhulina Maity, Susan Cherian, K. Dhama|
|Abstract: Rabies is a fatal viral zoonosis caused by lyssavirus. It affects warm blooded animals and humans. It is more prevalent in Asia, Africa and the Latin American countries. Although the exact magnitude of the disease is not reliably known, some studies estimated that 174 lakh persons are bitten by dogs and approximately 20,000 persons succumb to the disease annually. Global Alliance for Rabies Control estimated annual economic losses because of rabies in India is more than 2000 US dollars, mostly due to premature deaths, cost of vaccines, lost income for victims of animal bites and other costs. In spite of policies aimed for elimination of rabies, the same continues its reign as the most feared among the incurable human diseases, having rare declining trend. Being a neurotropic virus with variable incubation period within the host, death becomes inevitable once the pathogenesis has started with discernible clinical symptoms. Prompt diagnosis of the suspected cases is indispensable for effective cure and control of rabies. The diagnostic procedure recommended by OIE and FAO is direct fluorescent antibody test (dFAT). More than 3 million vaccine units are used annually as post-exposure prophylaxis in India. Both pre-exposure and post-exposure prophylactic vaccines for humans and animals are available for control and prevention of rabies. A greater impetus aimed for enhanced awareness of the disease, improvements in diagnosis and regular vaccination of target species shall hopefully free the globe from dog-mediated human rabies by 2030.|
|Full Text: 1 Introduction Rabies is a fatal disease posing serious public health concern, particularly in Asia and Africa (Singh et al., 2017). The word rabies has its origin from the Latin word ‘rabere’ which means ‘to be mad’. History and clinical recognition of rabies dates to twenty third century BC, where the first reference to animal rabies was recorded in the laws of Eshunna in Mesopotamia. Demonstration of neurotropism of the virus and the development of a rabies vaccine followed by its successful administration by Louis Pasteur during 1980’s was a great triumph in the history of rabies. With the advent of science and modern understanding of the virus and its immune protection, highly effective vaccines for the prevention and control of rabies have been developed. Despite the availability of safe and effective vaccines and understanding of the disease, the dog-mediated rabies causes approximately 61,000 annual deaths worldwide in humans, of which about 16,450 cases occur in India alone (WHO, 2013). The reasons being lack of awareness about the bite wound cleaning, vaccination, use of anti-rabies immunoglobulins in bite cases, non availability of the vaccines in remote places, etc. Due to under-reporting, rabies falls among the eighteen Neglected Tropical Diseases (Hampson et al., 2015). The true burden remains underestimated as the diagnostic facilities and disease surveillance are restricted in both animals as well as humans. Regardless of the concerted efforts made on global scale, with enhanced focus on implementation of control schemes and awareness programmes, the disease remains endemic in Asia and Africa, contributing 95% of reported cases worldwide (WHO, 2013). Rabies is completely preventable through exhaustive mass immunization of dogs and post-exposure prophylaxis (PEP) of humans as well as animals. It is imperative to create awareness among the vulnerable population to avoid exposure (Balaram et al., 2016). Rabies virus (RABV) induces mild to severe neurological signs described as furious and dumb forms, followed by paralysis, coma and death. The rabies virus circulates in two interrelated cycles, the first one involving domestic mammals (predominantly dogs and cats) and the second one involving wild mammals (mongoose, fox, raccoon, wolf, jackal, badger, bat, etc.) (Kuzmin et al., 2012). Stray dogs and probably jackals in India are the main vectors or reservoirs that sustain the disease in humans and other animals through bite of the infected ones (Singh et al., 2017). Bat mediated rabies, which is most prevalent in Latin American countries, has not been reported in India. With the aim to eradicate the dog-borne rabies in humans by 2030, Global Alliance for Rabies Control (GARC), a non-profit organization in collaboration with international rabies stakeholders (WHO/OIE/FAO) and various other communities is engaged in rabies control activities. They have been working over a decade, hand-in-hand, at local, national and global levels raising awareness as well as financial support. Apart from such collective approaches, several intersectoral projects were launched in rabies endemic countries within Asia and Africa for the elimination of dog-mediated rabies that involves enhanced educational awareness and mass immunization of dogs at risk (WHO, 2015). The present review emphasizes the current status, epidemiology, prevention and control strategies of rabies especially in Indian context. 2 Rabies virus Rabies virus is a, negative sense, single-stranded, enveloped, bullet shaped RNA virus of the genus Lyssavirus under the family Rhabdoviridae. Presently, 7 distinct genotypes of RABV have been found to circulate in nature. Classical rabies virus genotype 1 (street and laboratory strains) is the globally prevalent and causing disease in >99% cases in humans as well as animals (King et al., 2011). The other 6 genotypes named as rabies- related viruses (RRVs) such like Lagos bat virus (genotype-2), Mokola bat virus (genotype-3), Duvenhage virus (genotype-4), European bat Lyssaviruses (genotypes-5 and 6), and Australian bat Lyssavirus (genotype-7), are prevalent in certain areas of Africa, Western and Eastern Europe and Australia (Gould et al., 1998; Heaton et al., 1999). The fatal classical rabies - like disease in humans as well as animals is known to be caused by all the RRVs, except Lagos bat virus. So far, the role of RRVs has been established in the death of 5 human patients (Smith, 1996). The genome of RABV contains 5 highly conserved genes in the following order from 3' leader sequence, N, NS, M, G and L (Yousaf et al., 2012). The N gene encodes a highly conserved nucleoprotein with ‘group specific’ antigenic determinants shared by all rabies viruses and is exploited for diagnosis and virus identification. The G gene encodes trans-membrane glycoprotein, a ‘serotype specific’ antigen responsible for pathogenesis and induces neutralizing antibodies in the host (Singh et al., 2017). 3 Epidemiology of rabies Rabies affects all warm blooded animals and incidences have been reported from all continents except Australia and Antartica (Singh et al., 2017). Asia remains the hot spot in terms of both incidences and reservoirs. In Asia, over 3 billion human beings are at the risk of canine mediated rabies and it witnesses 30000 deaths annually (1 death every 15 minutes). The mortality rate in children below 15 years of age is more. The South Asian region records a maximum incidence of rabies outbreak, with India and Bangladesh in the lead. Other nations in the region and its vicinity with a considerable prevalence of rabies are Nepal, Bhutan, Myanmar, Thailand and Indonesia. The prevalence across domesticated species of animals in the region is in the range of 20-50%. In India, rabies is widely prevalent except Andaman and Nicobar islands (Sehgal & Bhatia, 1985). Increasing trend in stray dog population, urbanization and the lack of environmental hygiene among the densely populated rural communities are considered as critical risk factors in the predominance of rabies in Asian as well as African countries. On the contrary, European nations zero down rabies in humans by compulsory vaccination in animals, especially in dogs (Singh et al., 2017). |
4 TransmissionThe susceptibility of animals to RABV depends on several factors and there is difference in the reservoirs of disease among different geographical regions. Various studies have documented prevalence of rabies as 61.4% in cattle and buffaloes, 48.7% in goats, 48% in dogs, 45% in horses and 21.9% in cats (WHO, 2005; Sudarshan et al., 2006; Singh et al., 2017). Rabies outbreaks in domestic and wild animals in India are reported round the year with all such cases traced back to the bite of rabid dogs (Singh et al., 1990; Singh et al., 1995). According to the National Health Profile-2015, Ministry of Health and Family Welfare (MoHFW), Government of India (GOI), 104 cases has been reported from January to December, 2014 and the number showed a decline from the 132 cases of human rabies during 2013. West Bengal and Uttar Pradesh recorded maximum number of rabies outbreaks during 2014. In > 99% cases of human rabies worldwide, rabid dog has been found as a main source of infection (WHO, 2013). Eradication efforts in endemic countries have suffered heavily from systemic deficiencies, starting with under-reporting that has hampered synergized global response by hiding its real magnitude (Singh et al., 2017). A study conducted from 11 states/union territories of India during January 2012 to December 2014 showed about 52.3% of rabies cases were from Karnataka, 18% from Maharashtra, 7.8% from Tamil Nadu, 6.3% from Kerala and 3.1% from Andhra Pradesh states. West Bengal was the worst affected state, with 47 rabies deaths in 2016, followed by Karnataka with 19 deaths (Mani et al., 2016). Rabies in human beings develops from the bites of infected animals, predominantly dogs (91.5%) that have contracted the virus from feral or fellow infected creatures (Menezes, 2008). The transmission of virus occurs only when the saliva of the infected animal comes into contact with a broken skin or mucous membrane (Figure 1). The risk associated with the infection is reported to be high through the bite (5%-80%) than scratches or licks (0.1% -1%) from the affected animal. Fatality depends on the site of bite and the quantum of virus in the saliva of bitten rabid animal (Hemachudha et al., 2013). However, disease transmission through non- bite exposures such as cornea and organ transplants and contact with the infected materials such as brain tissues have also been reported (Winkler et al., 1973; Gibbons, 2002; Hellenbrand et al. 2005; Takayama, 2005; Milton et al., 2015). Bat colonies are known wildlife reservoirs for RABV variants in northern hemispheres. Invasive activities like skinning of infected animals accompanied with improper operating procedures enhances the risk of contraction of disease. Transmission through gastro-intestinal tract has also been documented (CDC, 1999). Exposure to live attenuated vaccines during the production stage may have potential risk. The persons who are involved in capturing the animals for birth control programmes are also at potential risk because of the threat of bite and scratch. Even though birds have all along been considered to be resistant to rabies, an unusual case of natural rabies virus infection following the bite of rabid dog has been reported recently in Kerala, India (Baby et al., 2015). 5 Pathogenesis Detailed pathogenesis of rabies virus has been recently reviewed by Singh et al. (2017). The sequence of events in the disease process involves: 1) replication of the virus in the peripheral tissues, 2) spread along the peripheral nerves and the spinal cord to the brain, 3) dissemination within the central nervous system (CNS) and its 4) centrifugal spread along nerves to various tissues and organs. These sequential steps have been elucidated from a number of experiments in mouse models using laboratory fixed strains (Mifune et al., 1980). Although these events may not mimic closely the natural disease process either in human or in rabies vector, yet understanding of these events is necessary for treatment and control of the disease. 5.1 Entry of virus The RABV binds neurons or muscle cells through receptors on the cell surface. A critical step in the disease process of street virus which differs from fixed virus is the involvement of muscle cell and occasional fibroblast infection (Johnson, 1965; Coulon et al., 1989). The virus remains undetected at the site when it enters an eclipse phase and replicates in muscles sequestered at or near the ingress site prior to nerve entry (Murphy et al., 1973). After the variable incubation period, the uptake of virus is completely restricted to motor end plates and axons in the peripheral nervous system (PNS) through receptor mediated endocytosis without affecting the sensory and autonomic nerve endings (Ugolini, 2008). However, there is a possible chance of transmission of bat RABV variants via sensory or sympathetic skin innervation (Ugolini, 2011). Velandia-Romero et al. (2013) reported that large sensory neurons preferentially capture and passage RABV to the dorsal root ganglion after inoculation in plantar foot-pad of adult mice. Nicotinic acetylcholine receptor (nAchR) is localized in the post synaptic membrane of motor neurons, neuromuscular junction (NMJ) on myotubes and in neurons of the CNS. Binding to nAchR concentrates the virus at the NMJ and aids in the uptake by nerve terminals by binding of RABV-G to micro-domains formed by another protein receptor known as neural cell adhesion molecule (NCAM)/ CD56 through gangliosides (Lafon et al., 2008). NCAM is present in cell bodies of pre-synaptic membranes of neurons of CNS as well as non-myelinated axons of the PNS. Low affinity neurotrophin receptor /p75NTR is the third protein receptor expressed at synapses of neurons (Tuffereau et al., 1998). Direct penetrating injury facilitates direct entry of virus to nerve terminals without replication in muscle (Coulon et al., 1989; Shankar et al., 1991). 5.2 Replication of virus Upon getting endocytosed in the peripheral neurons, transmission of virus to the CNS occurs by fast retrograde axoplasmic flow, but drugs and neurectomy prevent spread, whereas binding with p75NTR facilitates transcytosis (Gluska et al., 2014). The virus then reaches the neurons of the CNS in dorsal root ganglia and spinal cord where it multiplies and further spread to brain. Rapid multiplication of the virus is facilitated in almost all areas of the brain, however, with minimal pathological findings. Affection of neurons in limbic areas of brain results in behavioural changes, which leads to transmission through bite of infected animals. Neuronal dysfunction rather than neuronal damage is believed to be the mechanism by which RABV causes disease (Tsiang, 1982). The possible mechanisms of neuronal dysfunction were extensively studied and described as alteration of neurotransmission (Dumrongphol et al., 1996), disturbance of ion channels (Iwata et al., 1999), degeneration of neuronal processes and synaptic structure disruption (Li et al., 2005), down regulation of protein synthesis (Dhingra et al., 2007) and increased production of nitric oxide (Nakamichi et al., 2004). The possible strategy employed by the virus to favour its advancement through the nervous system is inhibition of apoptosis as there is an inverse relation between induction of apoptosis and the capacity of a RABV strain to invade brain (Thoulouze et al., 2003). By slow centrifugal anterograde axoplasmic flow, the virus moves from the CNS to muscle spindles, skin, hair follicles, salivary glands, lungs, heart muscle and abdominal visceral organs (Hemachudha et al., 2002). 5.3 Evasion strategies of virus The evasion strategy used by RABV is by inhibiting both innate and adaptive immune responses. Toll - like receptor 3 (TLR3) is an intracellular innate immune receptor in neurons (Jackson et al., 2006). In normal neurons, TLR3 is present within the endosomes in the neuronal cytoplasm; however, RABV sequesters TLR3 in Negri bodies (Menager et al., 2009). As there is lack of antigen presenting cells and lymphatic drainage, the CNS cannot induce an adaptive immune response against RABV. However, activated T cells especially CD8+ T cells and monocytes cross the intact blood-brain barrier but undergo death (Lafon, 2008). B cells needs disruption of the barrier in order to reach brain (Hooper et al., 2009). Antibody response is elicited during the later phase of infection with a low titre in the CSF, the source of which is not clear whether; it is from the virus in the periphery or from CNS (Johnson et al., 2010). RABV adopts stealth to keep away from stimulating the neutralizing host immunity by regulating the rabies virus glycoprotein (RABV-G) expression at the infection site as well as in neural tissues during its movement towards the CNS and there is an inverse association between pathogenicity and RABV-G expression (Yan et al., 2001; Zhang et al., 2013). On contrary, Wirblich & Schnell (2011) surmised that the RABV-G expression level plays a role in pathogenicity, but it will not attenuate a pathogenic RABV and is not a decisive dominant factor. 6 Diagnosis of rabies Prompt and precise laboratory diagnosis of rabies in humans and animals is imperative for astute administration of post-exposure preventive measures (Figure 1). The clinical signs of rabies are misdiagnosed with other neurological disorders, therefore cannot be relied upon. The isolation of RABV in albino mouse, cell lines like Neuro2a/CCL 131, BHK- 21/C13, Vero and McCoy are the most dependable and consistent methods in diagnosis of rabies. The CCL 131 cell line without any adaptation is most susceptible to street RABV. The results are obtained in 18 h post inoculation and hence routinely preferred for isolation (Shankar, 2009). An alternative highly sensitive method is mouse inoculation test (MIT), which is also used principally in developing countries (Singh et al., 2017). Many laboratories are targeting Negri bodies in brain impressions and sections using Seller’s and Mann’s staining till date. Due to poor sensitivity of these tests, direct fluorescent antibody test (dFAT) is the most comprehensively recommended test for diagnosis and interpretation of rabies in fresh brain samples in animals (WHO, 2013). An indirect rapid immuno-histochemistry test (IRIT) has been established and evaluated to detect as well as differentiate RABV variants; however, it needs further evaluation by traditional microscopy. So, a direct rapid immunohistochemical test (dRIT) for detection of rabies in humans as well as animals has also been developed (Madhusudana et al., 2012). Lateral flow technique employing immunochromatographic principle having 100% specificity and more than 88% sensitivity enabled the early diagnosis of diverse rabies virus strains (RABV species 1, 5, 6 and 7) when compared to earlier mentioned tests (Servat et al., 2012). RT-PCR–ELISA has recently been identified for the detection of RABV (AravindhBabu et al., 2014). The dFAT, having 100% sensitivity to detect virus from fresh brain tissues is used regularly by all the laboratories envisaged to diagnose rabies and confirmative diagnosis can be made within 2 h. Moreover, the dFAT has also been found appropriate to detect rabies positive cases (100%) even in formalin-fixed or paraffin-embedded materials (Singh et al., 2017). Serological tests are rarely used to diagnose rabies as the infected animal or human do not survive the disease long enough to release sufficient antibodies to detect its presence in serum. Serological tests are usually employed for detection of rabies antibodies by targeting G and N proteins and are chiefly used to assess potency of various rabies vaccines (Wasniewski & Cliquet, 2012). Serum neutralizing tests are employed for virus serotyping that requires mouse neuroblastoma cells and G-protein reactive monoclonal antibodies (mAb-Gs). The approaches currently recommended by WHO to estimate RABV neutralizing antibodies are rapid fluorescent focus inhibition test (RFFIT) and fluorescent antibody virus neutralization test (FAVN) (Cliquet et al., 1998). A minimum measurable protective antibody titre of 0.5IU/ml represents the level of immunity in humans and animals to rabies infection (OIE, 2016). For the transport of pet dogs from countries considered infected with rabies, an international veterinary certificate must be produced indicating that the animal has not shown any signs of rabies on the day or prior to the travel and were either vaccinated or revaccinated against rabies following the standard protocol or should have undergone an antibody titration test not less than 3 months or not more than 12 months prior to the day of travel with a protective antibody titre of not less than 0.5IU/ml. RFFIT is widely used to estimate the sero-conversion following preventive measures like prophylactic vaccination, and to help clinical detection of rabies in suspected cases. Diagnosis of RABV nucleic acid in the clinical samples like cerebrospinal fluid (CSF), saliva, skin biopsy and corneal impression smear by polymerase chain reaction (PCR) is documented as reliable for the ante-mortem diagnosis of rabies (Madhusudana & Sukumaran, 2008). Other tests which are established, which are in use in WHO or World Organization for Animal Health (OIE) reference laboratories to diagnose rabies includes tests based on the detection of nucleic acid like in situ hybridization, genome sequencing, etc (Singh et al., 2017). These methods are able to detect extremely specific viral RNA molecular subunits in brain material of experimental or routine specimens. PCR based tests are established for studying viral pathogenesis and epidemiological analysis apart from diagnosis. Though FAT can detect RABV within 2 h of receiving sample, it is not sensitive with RRVs and fails in the decomposed tissues (Heaton et al., 1999). In contrast, PCR being independent on such conditions detect even few numbers of viral particles in such samples (Singh et al., 2017). There are no diagnostic tests available to diagnose rabies in humans during pre-clinical phase, and till the rabies-pathognomonic signs like hydrophobia or aerophobia are developed, the clinical diagnosis might be difficult (Chacko et al., 2016). Several tests are required for diagnosis of rabies ante-mortem in humans due to the variability of the virus in different samples, the timing of collection of sample, and the antibody response of the host. Clinical samples like saliva, serum, spinal fluid, and skin biopsies of hair follicles at the neck region can be included for diagnostic tests (Warrell & Warrell, 2004). Conventional RT-PCR, Real-time PCR, Direct dot-blot enzyme immunoassay (EIA) on saliva and Polymerase chain reaction (RT-hnPCR) on skin biopsy (non-neural) are available with variable sensitivity and 100% specificity (Madhusudana et al., 2004; Nagaraj et al., 2006; Dacheux et al., 2008; Chacko et al., 2016). Saliva is a sample of choice for virus isolation as well as reverse transcription polymerase chain reaction (RT-PCR). Moreover, serum and spinal fluid can be tested for antibodies against rabies virus. Skin biopsy materials are examined for rabies antigen in the cutaneous nerve endings at the base of hair follicles (Madhusudana & Sukumaran, 2008; Dacheux et al., 2008). 7 Vaccination approaches in control of rabies: Pioneering anti-rabies immunization was performed on a boy (Joseph Meister) by Louis Pasteur in late phase of 19th century. After that plenty of effective and safe, second and third generation vaccines have been developed for use in animals and humans. Currently, a number of vaccines such as recombinant rabies virus strains or rabies antigen-glycoprotein (G protein), either as a component of non-pathogenic viruses, or in plants / form of DNA vaccines are being developed (Ohara et al., 2013). To stimulate the host immunity against rabies infection, normally different forms (live intact, inactivated, attenuated) or purified components of pathogens (outer coat proteins of rabies virus) with high immunogenicity are used. This generates immune response within 2 weeks. These vaccines are administered by IM or ID routes. If dog population is sufficiently (>70%) covered by rabies vaccination, it will reduce the disease burden in humans. Currently, the rabies vaccines are accessible to prevent and control rabies in animal population (dogs, cats, wild carnivores and bats). The vaccines administered within first few days of post-exposure are reported to decrease the disease by attenuating the virus considerably. Later on the 4 dose series (day 0, 3, 7 and 14) would take care. Treatment of the category III wounds (single or multiple transdermal bites or scratches, licks on broken skin; contamination of mucous membrane with saliva from licks) with rabies immunoglobulin (RIG) should be commenced as soon as possible after exposure to prevent disease development in human. In the United States alone, 11 different categories of rabies vaccines are licensed for dogs, 12 for cats, 5 for sheep, 4 for cattle, 3 for horses, and 1 for ferrets (Briggs et al., 2007). The most challenged obstacle to develop vaccines for rabies is the need to work with the active virus, for which appropriate bio safety levels are essential. Virus like particles (VLPs) seems to be promising in this context for development of rabies vaccine. The efficacy of glycoprotein sequences of Pasteur virus (PV), Challenge Virus Standard (CVS), Evelyn- Rokitnicki-Abelseth (ERA), or street virus isolates as DNA vaccines have been evaluated. Also, the advancement in science in the recent years has made momentous progress in the design of vectors suited for gene delivery of the virus components. However, drawbacks related to poor immunogenicity and requirement of larger doses of DNA in animals remain as a fathomless issue in rabies DNA vaccination (Yang et al., 2013). Glycoprotein expressed on the surface of the vaccinia virus, canary pox virus (Yang et al., 2013), canine adenovirus (Zhang et al. 2008), chimeric lyssavirus glycoprotein with segments from Rabies virus and Mokola virus (Badrane et al., 2001) are the recombinant vaccines which provide immunization against more than one lyssavirus. DNA vaccination with glycoprotein cloned into a plasmid vector has also been developed as vaccines against rabies. Vaccination in wild animals is an essential part in control of rabies so as to prevent its spread to domestic animals and human. Oral Rabies Vaccine (ORV) laden baits have been successfully established for red, Arctic, and gray foxes; coyotes, raccoon dogs, raccoons, skunks, and domestic dogs (Yang et al., 2013). ORV was explicated to vaccinate free-ranging wild animals in geographically large enzootic areas, to subjugate the development and extent of a rabies epizootic, or to establish a rabies-free buffer zone (Muller et al., 2001). Vaccination for rabies can be either pre- or post-exposure. Pre-exposure vaccination is performed to safeguard those who are at high risk of rabies exposure. Post-exposure vaccination is performed after the bite of rabies suspected animal to prevent the development of disease. The vaccines used for pre-exposure and post-exposure prophylaxis remains the same, but the schedule varies. Inactivated animal nerve tissue vaccines (NTV) from rabbit brain and later sheep and goat brain were used previously, but later discontinued due to the high levels of myelin that caused sensitization in some vaccine recipients and, in extreme cases, fatal encephalitis (Fishbein et al., 1993; Hicks et al., 2012). In India, NTV was used for post-exposure treatment, but the production was stopped in December, 2004 due to the adverse reactions. NTV was later replaced by cell culture adopted or embryonated egg passaged vaccines which were found safer and more efficient than older vaccines. 7.1 Pre-exposure vaccination
Annadurai K, Danasekaran R, Mani G (2014) Rabies in India: A relook at the neglected rampant disease. The Journal of Neurobehavioral Sciences 1: 88-91.
Aravindh Babu RP, Manoharan S, Ramadass P, Chandran ND (2012) Evaluation of RT-PCR assay for routine laboratory diagnosis of rabies in post mortem brain samples from different species of animals. Indian Journal of Virology 23 : 392-6.
AravindhBabu RP, Manoharan S, Ramadass P (2014) Diagnostic evaluation of RT-PCR–ELISA for the detection of rabies virus. Indian Journal of Virology 25 :120–124.
Aravindhbabu RP, Manoharan S, Ramadass P, Chandran ND (2011) Rabies in South Indian cows: An evidence of Sri Lankan rabies virus variant infection based on the analysis of partial nucleoprotein gene. Indian Journal of Virology 22 : 138-41.
Ashwath Narayana DH, Madhusudana SN, Sampath G, Tripathy RM, Sudarshan MK, Gangaboraiah, Ravish HS, Satapathy DM, Gowda G, Holla R, Ashwin BY, Padhi A, Manjula S, Patel PM (2014) Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India. Human Vaccines & Immunotherapeutics 10 : 120-5.
Baby J, Mani RS, Abraham SS, Thankappan AT, Pillai PM, Anand AM, Madhusudana SN, Ramachandran J, Sreekumar S (2015) Natural rabies infection in a domestic fowl (Gallus domesticus): A Report from India. PLoS Neglected Tropical Diseases 9: e0003942.
Badrane H, Bahloul C, Perrin P, Tordo N (2001) Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity. Journal of Virology 75: 3268-3276.
Balaram D, Taylor LH, Doyle KAS, Davidson E, Nel H (2016) World rabies day- a decade of raining awareness. Tropical Diseases, Travel Medicine and Vaccine 2: 1-9.
Bansal K, Singh CKK, Ramneek, Sandhu BS, Deka D, Dandale M, Sood NK (2012) Antemortem diagnosis of rabies from skin: comparison of nested RT-PCR with TaqMan real time PCR. Brazilian Journal of Veterinary Pathology 5: 116–119.
Briggs DJ, Dreesen DW, Wunner WH (2007) Vaccines. In: Jackson AC, Wunner WH, (Eds.), Rabies. San Diego (CA): Academic Press; Pp. 545–66.
Brookes VJ, Gill GS, Singh CK, Sandhu BS, Dhand NK, Singh BB, Gill JPS, Ward MP (2018) Exploring animal rabies endemicity to inform control programmes in Punjab, India. Zoonoses Public Health 65 : e54-e65.
Byrnes H, Bhutia T (2011) Sikkim anti-rabies and animal health programme - a local solution in a small state of India. EcoHealth 7: S61-S61.
Byrnes H, Britton A, Bhutia T (2017) Eliminating dog-mediated rabies in Sikkim, India: A 10-year pathway to success for the SARAH program. Frontiers in Veterinary Science 4:28.
CDC (1999) Mass treatment of humans who drank unpasteurized milk from rabid cows. Morbidity Mortality Weekly Report 48:228–230.
Chacko K, Parakadavathu RT, Al-Maslamani M, Nair AP, Chekura AP, Madhavan I (2016) Diagnostic difficulties in human rabies: A case report and review of the literature. Qatar Medical Journal 2:15. doi: 10.5339/qmj.2016.15.
Cherian S, Singh R, Singh KP, Reddy GM, Kumar GR, Sumithra TG, Singh RP (2015) Phylogenetic analysis of Indian rabies virus isolates targeting the complete glycoprotein gene. Infection, Genetics and Evolution 36: 333-338.
Cliquet F, Aubert M, Sagne L (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. Journal of Immunological Methods 212:79–87.
Cliquet F, Gurbuxani JP, Pradhan HK, Pattnaik B, Patil SS, Regnault A, Begouen H, Guiot AL, Sood R, Mahl P, Singh R, Meslin FX, Picard E, Aubert MF, Barrat J (2007) The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine 25:3409-3418.
Coulon P, Derbin C, Kucera P, Lafay F, Prehaud C, Flamand A (1989) Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative. Journal of Virology 63: 3550–3554.
Dacheux L, Reynes J-M, Buchy P, Sivuth O, Diop BM, Rousset D, Rathat C, Jolly N, Dufourcq JB, Nareth C, Diop S, Iehlé C, Rajerison R, Sadorge C, Bourhy H (2008) A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clinical Infectious Diseases 47 : 1410–1417
Dandale M, Singh CK, Ramneek V, Deka D, Bansal K, Sood NK (2013) Sensitivity comparison of nested RT-PCR and TaqMan real time PCR for intravitam diagnosis of rabies in animals from urine samples. Veterinary World 6 :189-192.
Dhingra V, Li X, Liu Y, Fu ZF (2007) Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. Journal of Neurovirology 13: 107–117.
Diksha K, Chauhan RS, Saminathan M, Dhama K, Malik YS (2018) Rabies immunization in animals and man – An overview. Journal of Immunology and Immunopathology 20 : 1-13.
D'Souza BA, Rao JR, Victor DA, Khader TG (1968) A preliminary investigation of the role of Bandicota malabarica in the transmission of rabies among dogs in the city of Madras. Indian Veterinary Journal 45 : 633-8.
Dumrongphol H, Srikiatkhachorn A, Hemachudha T, Kotchabhakdi N, Govitrapong P(1996) Alteration of muscarinic acetylcholine receptors in rabies viral infected dog brains. Journal of the Neurological Sciences 137: 1–6.
Fishbein DB, Sawyer LA, Reid-Sanden FL, Weir EH (1988) Administration of human diploid-cell rabies vaccine in the gluteal area. The New England journal of medicine 318 :124-5.
Fishbein DB, Yenne KM, Dreesen DW, Teplis CF, Mehta N, Briggs DJ (1993) Risk factors for systemic hypersensitivity reactions after booster vaccination with human-diploid cell rabies vaccine-a nationwide prospective study. Vaccine 11: 1390–1394.
GARC (2017) Towards a rabies-free world as unparalleled global initiative gets underway. Available on https://rabiesalliance.org/news/towards-rabies-free-world access on 29th November, 2017
Gibbons RV (2002) Cryptogenic rabies, bats, and the question of aerosol transmission. Annals of Emergency Medicine 39:528–536.
Gibson AD, Ohal P, Shervell K, Handel IG, Bronsvoort BM, Mellanby RJ, Gamble L (2015) Vaccinate-assess-move method of mass canine rabies vaccination utilising mobile technology data collection in Ranchi, India. BMC Infectious Diseases 15: 589.
Gluska S, Zahavi EE, Chein M, Gradus T, Bauer A, Finke S, Perlson E (2014) Rabies virus hijacks and accelerates the p75NTR retrograde axonal transport machinery. PLoS Pathogens 10 :e1004348.
Gould AR, Hyatt AD, Lunt R, Kattenbelt JA, Hengstberger S, Blackwell SD (1998) Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. Virus Research 54: 165–187.
Gupta PK, Dahiya SS, Kumar P, Rai A, Patel CL, Sonwane AA, Saini M (2009) Sindbis virus replicon-based DNA vaccine encoding Rabies virus glycoprotein elicits specific humoral and cellular immune response in dogs. Acta Virologica 53 :83-8.
Gupta PK, Rai A, Rai N, Saini M (2005a) Immunogenicity of a plasmid DNA vaccine encoding glycoprotein gene of rabies virus CVS in mice and dogs. Journal of Immunology and Immunopathology 7: 58-61.
Gupta PK, Sharma S, Walunj SS, Chaturvedi VK, Raut AA, Patial S, Rai A, Pandey KD, Saini M (2005b) Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus. Veterinary Microbiology 108 : 207-214.
Gupta PK, Singh RK, Sharma RN, Rao YUB, Butchaiah G (2001) Preliminary Report on a single-tube, non-interrupted Reverse Transcription–Polymerase Chain reaction for the detection of rabies virus in brain tissue. Veterinary Research Communications 25 : 239-247.
Gupta PK, Sonwane AA, Singh NK, Meshram CD, Dahiya SS, Pawar SS, Gupta SP, Chaturvedi VK, Saini M (2012) Intracerebral delivery of small interfering RNAs (siRNAs) using adenoviral vector protects mice against lethal peripheral rabies challenge. Virus Research 163 : 11-8.
Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P (2015) Estimating the global burden of endemic canine rabies. PLOS Neglecetd Tropical Diseases 9 : e0003709.
Heaton PR, McElhinney LM, Lowings JP (1999) Detection and identification of rabies and rabies related viruses using rapid - cycle PCR. Journal of Virological Methods 81:63–69.
Hellenbrand W, Meyer C, Rasch G, Steffens I, Ammon A (2005) Cases of rabies in Germany following organ transplantation. Eurosurveillance Weekly Release 10:050217.
Hemachudha T, Laothamatas J, Rupprecht CE (2002) Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurology 1: 101–109.
Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, ShuangshotiS, Laothamatas J (2013) Human rabies: neuropathogenesis, diagnosis and management. Lancet Neurology 12: 498–513.
Herbert M, Basha R, Thangaraj S (2012) Community perception regarding rabies prevention and stray dog control in urban slums in India. Journal of Infection and Public Health 5 : 374-380.
Hicks DJ, Fooks AR, Johnson N (2012) Developments in rabies vaccines. Clinical & Experimental Immunology 169 : 199-204.
Hooper DC, Phares TW, Fabis MJ, Roy A (2009) The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Neglected Tropical Diseases 3 : e535.
Iwata M, Komori S, Unno T, Minamoto N, Ohashi H (1999) Modification of membrane currents in mouse neuroblastoma cells following infection with rabies virus. British Journal of Pharmacology 126: 16919–1698.
Jackson AC, Rossiter JP, Lafon M (2006) Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. Journal of Neurovirology 12: 229–234.
Jamadagni SB, Singh CK, Sandhu BS (2007) Histopathological alterations in brains of rabies infected buffaloes and cattle. Italian Journal of Animal Science 6 : 872-874.
Jayakumar R, Nachimuthu K, Padmanaban VD (1995) A Dot enzyme linked immunosorbent assay (Dot ELISA): comparison with standard fluorescent antibody test (FAT) for the diagnosis of rabies in animals. Comparative Immunology, Microbiology & Infectious Diseases 18 : 269-73.
Jayakumar R, Padmanaban VD (1994) A dipstick dot enzyme immunoassay for detection of rabies antigen. Zentralblatt Fur Bakteriologie 280 :382-5.
Jayakumar R, Ramadass P (1990) Studies on cell-mediated immune response to rabies virus immunization in dogs. Vaccine 8 :304-5.
Jayakumar R, Ramadass P (1991) Immunoglobulin response to rabies virus immunization in dogs. Vaccine 9 : 611-2.
Jayakumar R, Ramadass P, Raghavan N (1989) Comparison of enzyme immunodiagnosis with immunofluorescence for rapid diagnosis of rabiesin dogs. Zentralblatt Fur Bakteriologie 271 : 501-3.
Jayakumar R, Thirumurugan G, Nachimuthu K, Padmanaban VD (1996) Detection of rabies virus antigen in animals by avidin-biotin dot ELISA. Zentralblatt Fur Bakteriologie 285 : 82-5.
Jemima EA, Manoharan S, Kumanan K (2014) Development and evaluation of a recombinant-glycoprotein-based latex agglutination test for rabies virus antibody assessment. Archives of Virology 159 : 1987-93.
Johnson N, Cunningham AF, Fooks AR (2010) The immune response to rabies virus infection and vaccination. Vaccine 28 : 3896-3901.
Johnson RT (1965) Experimental rabies. Studies of vulnerability and pathogenesis using fluorescent antibody staining. Journal of Neuropathology and Experimental Neurology 14: 662–675.
Kakkar M, Venkataramanan V, Krishnan S, Chauhan RS, Abbas SS (2012) Moving from rabies research to rabies control: Lessons from India. PLOS Neglected Tropical Diseases 6: e1748.
Kaw A, Singh CK, Sandhu BS, Sood NK, Deka D, Awahan S (2011) Diagnosis of rabies in animals by nested RT-PCR. Indian Journal of Animal Sciences 81 : 367–69.
King AM, Lefkowitz E, Adams MJ, Carstens EB(2011) Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. In: King AMQ, Adams MJ, Carstens EB, Leftkowitc EJ (Eds.), Virus taxonomy, Elsevier Publication.
Krishna SC (2010) The success of the ABC-AR programme in India. FAO, 20 August 2010. Available on http://www.fao.org access on 29th November, 2017.
Kumar M, Singh RP, Mishra B, Singh R, Reddy GBM, Patel A, Saravanan R, Gupta PK (2010) Development of alternative approaches for in process quality control of rabies vaccine. Doctoral Thesis, submitted to Deemed University, IVRI, Izatnagar (India).
Kushwaha AN (2011) Combined effect of LPS and rabies immunoglobulin in pathogenesis of rabies in mouse model and study on spontaneous fetal brain affections in cattle and buffaloes. MVSc Thesis, submitted to Deemed University, IVRI, Izatnagar (India).
Kuzmin IV, Shi M, Orciari LA, Yager PA, Velasco-Villa A, Kuzmina N A, Streicker DG, Bergman DL, Rupprecht CE (2012) Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001–2009. PLoS Pathogen 8:e1002786.
Lafon M, Megret F, Meuth SG, Simon O, Velandia Romero ML, Lafage M, Chen L, Alexopoulou L, Flavell RA, Prehaud C, et al (2008) Detrimental contribution of the immuno-inhibitor b7-h1 to rabies virus encephalitis. The Journal of Immunology 180: 7506–7515.
Li XQ, Sarmento L, Fu ZF ( 2005) Degeneration of neuronal processes after infection with pathogenic, but not attenuated, rabies viruses. Journal of Virology 79:10063–10068.
Madhu BP, Singh KP, Saminathan M, Singh R, Shivasharanappa N, Sharma AK, Malik YS, Dhama K. Manjunatha V (2016a) Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. VirusDisease 27 : 387–399.
Madhu BP, Singh KP, Saminathan M, Singh R, Tiwari AK, Manjunatha V, Harish C Manjunathareddy GB (2016b) Correlation of inducible nitric oxide synthase (iNOS) inhibition with TNF-α, caspase-1, FasL and TLR-3 in pathogenesis of rabies in mouse model. Virus Genes 52 : 61–70.
Madhusudana SN, Paul JP, Abhilash VK, Suja MS (2004) Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassay. International Journal of Infectious Diseases 8 : 339-345.
Madhusudana SN, Subha S, Thankappan U, Ashwin YB(2012) Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans. Virologica Sinica 27:299–302.
Madhusudana SN, Sukumaran SM (2008) Antemortem diagnosis and prevention of human rabies. Annals of Indian Academy of Neurology 11 :3–12
Mani RS, Anand AM, Madhusudana SN (2016) Human rabies in India: an audit from a rabies diagnostic laboratory. Tropical Medicine & International Health 21 :556-63.
Manickama R, Basheer MD, Jayakumar R (2008) Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs. Vaccine 26: 6564-8.
Manjunatha V, Singh KP, Saminathan M, Singh R, Shivasharanappa N, Umeshappa CS, Dhama K, Manjunathareddy GB (2017) Inhibition of MEK-ERK1/2-MAP kinase signalling pathway reduces rabies virus induced pathologies in mouse model. Microbial Pathogenesis 112 :38-49.
Menager P, Roux P, Megret F, Bourgeois JP, Le Sourd AM, Danckaert A, Lafage M, Prehaud C, Lafon M (2009) Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri bodies. PLoS Pathogens. 5e1000315.
Menezes R (2008) Rabies in India. Canadian Medical Association Journal 178 : 564-6.
Meshram CD, Singh NK, Sonwane AA, Pawar SS, Mishra BP, Chaturvedi VK, Saini M, Singh RP, Gupta PK (2013) Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro. Archives of Virology 158: 2323-32.
Mifune K, Shichijo A, Marino Y, Takeughi E, Yamada A, Sakamoto K (1980) A mouse model for the pathogenesis and postexposure prophylaxis of rabies. Microbiology and Immunology 24 : 835-845.
Milton AAP, Priya GB, Aravind M, Parthasarathy S, Saminathan M, Jeeva K, Agarwal RK (2015) Nosocomial infections and their surveillance in veterinary hospitals. Advances in Animal and Veterinary Sciences 3 : 1-24.
Müller T, Schuster P, Vos A, Selhorst T, Wenzel U, Neubert A (2001) Effect of maternal immunity on the immune response to oral vaccination against rabies in young foxes. American Journal of Veterinary Research 62: 1154-1158.
Murphy FA, Bauer SP, Harrison AK, Winn WC Jr (1973) Comparative pathogenesis of rabies and rabies-like viruses. Viral infection and transit from inoculation site to the central nervous system. Laboratory Investigation 28: 361–76.
Nagaraj T, Vasanth JP, Desai A, Kamat A, Madhusudana SN, Ravi V (2006) Ante mortem diagnosis of human rabies using saliva samples: Comparison of real time and conventional RT-PCR techniques. Journal of Clinical Virology 36 : 17–23.
Nagarajan T, Mohanasubramanian B, Seshagiri EV, Nagendrakumar SB, Saseendranath MR, Satyanarayana ML, Thiagarajan D, Rangarajan PN, Srinivasan VA (2006) Molecular epidemiology of rabies virus isolates in India. Journal of Clinical Microbiology 44 : 3218-24.
Nagarajan T, Nagendrakumar SB, Mohanasubramanian B, Rajalakshmi S, Hanumantha NR, Ramya R, Thiagarajan D, Srinivasan VA (2009) Phylogenetic analysis of nucleoprotein gene of dog rabies virus isolates from Southern India. Infection, Genetics and Evolution 9(5): 976-82.
Nakamichi K, Inoue S, Takasaki T, Morimoto K, Kurane I (2004) Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2. Journal of virology 78 : 9376-9388.
NCDC (2015) National guidelines on rabies prophylaxis. Published by National Centre for Disease Control (Directorate General of Health Services), 22-Sham Nath Marg, Delhi, pp: 1-17. Available on www.ncdc.gov.in/writereaddata/mainlinkfile/File557.pdf access on 20th August, 2017.
NICD (2007) National Guidelines for Rabies Prophylaxis and Intra-dermal Administration of Cell Culture Rabies Vaccines. Published by National Institute of Communicable Diseases, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, New Delhi, pp: 1-27. Available on www.ncdc.gov.in/Rabies_Guidelines.pdf access on 20th August, 2017.
Ohara S, Sato S, Oyama K, Tsutsui KI, Iijima T(2013) Rabies virus vector transgene expression level and cytotoxicity improvement induced by deletion of glycoprotein gene. PloS One 8:e80245.
OIE (2016) The OIE rabies Vaccine Bank: A catalyst for rabies elimination strategies. Available on http://www.oie.int/en/for-the-media/press-releases/detail/article/the-oie-rabies-vaccine-bank-a-catalyst-for-rabies-elimination-strategies/ access on 20th August, 2017.
Patel AC, Upmanyu V, Ramasamy S, Gupta PK, Singh R, Singh RP (2015) Molecular and immunogenic characterization of BHK-21 cell line adapted CVS-11 strain of rabiesvirus and future prospect in vaccination strategy. Virus disease 26 : 288-96.
Patial S, Chaturvedi VK, Rai A, Saini M, Chandra R, Saini Y, Gupta PK (2007) Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Vaccine 25 : 4020-8.
Pradhan HK, Gurbuxani JP, Cliquet F, Pattnaik B, Patil SS, Regnault A, Begouen H, Guiot AL, Sood R, Mahl P, Singh R, Picard E, Aubert MF, Barrat J, Meslin FX (2008) New steps in the control of canine rabies in India. Developments in Biologicals 131: 157-66.
Rahman SA (2011) Towards sustainable prevention of rabies at source: Case report India, In: Compendium of the OIE global conference on rabies control, Incheon, Republic of Korea: 2011, September 7 to 9.
Ramya R, Verma PC, Chaturvedi VK, Gupta PK, Pandey KD, Madhanmohan M, Kannaki TR, Sridevi R, Anukumar B (2009) Poly (lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus. Vaccine 27 : 2138-2143.
Reddy GB, Singh R, Singh RP, Singh KP, Gupta PK, Mahadevan A, Shankar SK, Ramakrishnan MA, Verma R (2011) Molecular characterization of Indian rabies virus isolates by partial sequencing of nucleoprotein (N) and phosphoprotein (P) genes. Virus Genes 43 : 13-7.
Reddy MGB (2010) Molecular epidemiology and pathogenesis of Rabies. PhD Thesis, submitted to Deemed University, IVRI, Izatnagar (India).
Reece JF, Chawla SK (2006) Control of rabies in Jaipur, India, by the sterilisation and vaccination of neighbourhood dogs. Veterinary Record 159 : 379-83.
Ren J, Yao L, Sun J, Gong Z (2015) Zagreb Regimen, an abbreviated intramuscular schedule for rabies vaccination. In: Papasian CJ (Ed.) Clinical and Vaccine Immunology: CVI. 22: 1-5.
Sandhu BS, Sood NK, Awahan S, Singh CK, Gupta K (2011) Immunohistochemistry, histopathology, quantitative morphometry of negri bodies in the brain of rabid animals. Indian Journal of Veterinary Pathology 35 : 117-122.
Savaliya BF, Mathakiya RA, Bhanderi BB, Jhala MK (2015) Evaluation of phenotypic factors for anti-rabies antibody in vaccinated pet dogs. Virus disease 26 : 282-7.
Saxena S, Dahiya SS, Sonwane AA, Patel CL, Saini M, Rai A, Gupta PK (2008) A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Vaccine 26: 6592-6601.
Saxena S, Sonwane AA, Dahiya SS, Patel CL, Saini M, Rai A, Gupta PK (2009) Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Veterinary Microbiology 136 : 36-44.
Sehgal S, Bhatia R (1985) Rabies: current status and proposed control programme in India. New Delhi: National Institute of Communicable Diseases
Servat A, Picard-Meyer E, Robardet E, Muzniece Z, Kylli Must K, Cliquet F(2012) Evaluation of a rapid immunochromatographic diagnostic test for the detection of rabies from brain material of European mammals. Biologicals 40:61–66.
Shah U, Jaswal GS (1976) Victims of a rabid wolf in india: effect of severity and location of bites on development of rabies. The Journal of Infectious Diseases 134 : 25-9.
Shankar BP (2009) Advances in diagnosis of rabies. Veterinary World 2:74-78.
Shankar V, Dietzschold B, Koprowski H (1991) Direct entry of rabies virus into the central nervous system without prior local replication. Journal of Virology 65: 2736–2738.
Shankumar M (2010) Effect of lipopolysaccharide on molecular pathogenesis of rabies virus (CVS- 18 strain) in laboratory mouse model. MVSc Thesis, submitted to Deemed University, I.V.R.I., Izatnagar (India).
Sharma P, Singh CK, Narang D (2015) Comparison of immunochromatographic diagnostic test with Hheminested Reverse transcriptase polymerase chain reaction for detection of rabies virus from brain samples of various species. Veterinary World 8 : 135-8.
Shivasharanappa N (2008) Involvement of TLR-3 and TLR-3 induced cytokines in the pathogenesis of rabies in experimental mouse model. MVSc. Thesis, submitted to Deemed University, I.V.R.I., Izatnagar (India).
Shivasharanappa N, Singh R, Singh KP, Madhu BP (2011) NK cell and macrophage activity in experimentally induced rabies in mice. Indian Journal of Veterinary Pathology35: 159-161.
Singh CK (2008) Current knowledge on pathology and pathogenesis of rabies and its status in the country. Indian Journal of Veterinary Pathology 32 : 143-149.
Singh CK, Sandhu BS (2008) Rabies in South Asia: epidemiological investigations and clinical perspective. Developments in Biologicals 131: 133-6.
Singh MP, Goyal K, Majumdar M, Ratho RK (2011) Prevalence of rabies antibodies in street and household dogs in Chandigarh, India. Tropical Animal Health and Production 43 : 111-4.
Singh NK, Meshram CD, Sonwane AA, Dahiya SS, Pawar SS, Chaturvedi VK, Saini M, Singh RP, Gupta PK (2014) Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector. Molecular Biotechnology 56 :91-101.
Singh R, Mehrotra ML, Shukla DC (1990) A note on diagnosis of rabies. VII Annual Conference of IAVP Sep., 17-19, Tirupati.
Singh R, Shukla DC, Khanna PN, Singh KP, Mehrotra ML(1995) An outbreak of rabies in cattle and buffaloes in Uttar Pradesh. The Indian Journal of Animal Science 65:166-168.
Singh R, Singh KP, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy GB, Panda S, Dhama K (2017) Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Veterinary Quarterly 37 : 212-251.
Singh VK, Tiwari KN, Mohan B, Mala C, Rana UV, Ichhpujani RL (2007) Humoral response to rabies vaccines in pet dogs. Journal of Communicable of Diseases 39: 109-11.
Smith JS (1996) New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United State. Clinical Microbiology Reviews 9:166–176.
Sonwane AA, Dahiya SS, Saini M, Chaturvedi VK, Singh RP and Gupta PK (2012). Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice. Research in Veterinary Science 93: 498-503.
Sudarshan MK, Mahendra BJ, Madhusudana SN, Narayana DA, Rahman A, Rao NS, X-Meslin F, Lobo D, Ravikumar K (2006) An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. Journal of Communicable Diseases 38: 32.
Suja MS, Mahadevan A, Madhusudhana SN, Vijayasarathi SK, Shankar SK (2009) Neuroanatomical mapping of rabies nucleocapsid viral antigen distribution and apoptosis in pathogenesis in street dog rabies--an immunohistochemical study. Clinical Neuropathology 28 : 113-24.
Sumit S (2017) Effect of inhibition of TLR-3 on pathogenesis of rabies in mouse model. MVSc. Thesis, submitted to Deemed University, I.V.R.I., Izatnagar (India).
Takayama N (2005) Clinical feature of human rabies. Nippon Rinsho 63:2